Skip to main content
. 2022 Dec 6;14(12):2728. doi: 10.3390/pharmaceutics14122728

Table 3.

Selected clinical trials enlisted in clinicaltrials.gov website for marketed PLGA-based therapeutics. Reproduced from [10].

Brand Name Indication Clinicaltrials.Gov Identifier
Somatuline® LA Acromegaly NCT03066245
Sandostatin® LAR Acromegaly and carcinoid NCT03060655
Nutropin Depot ® Growth deficiency NCT02568527
Zoladex® Breast cancer. Prostate cancer NCT03474900
Arestin Periodontal disease NCT02726646
TrelstarTM Depot Advanced Prostatic Cancer NCT01681381
Suprecur® MP Prostate cancer NCT0 1753 089
Pamorelin® Prostate cancer NCT03045913
Lupron Depot Prostate cancer NCT02578069
Eligard Advanced Prostatic Cancer NCT03401216
Atridox® Chronic adult periodontitis NCT03429803
Risperidal® Consta Antipsychotic NA
Decapepty Prostate cancer NA